Gene GAS5 (with FDR = 3.11×10−19) was shown to have a novel role in microglial polarization and the pathogenesis of demyelinating diseases which suggested the potential therapeutic benefit of targeting GAS5 for the treatment of neurological disorders including AD [57]. Here, GAS5 is linked to nervous system disorder.